Screening of Gene Mutations in Lung Cancer for Qualification to Molecularly Targeted Therapies

doi 10.5772/48689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Dose Determination for Molecularly Targeted Therapies: Much Ado About Nothing

Cancer
Cancer ResearchOncology
2017English

Metal-Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics

European Journal of Inorganic Chemistry
Inorganic Chemistry
2016English

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Targeted Therapies for Esophageal Cancer

Oncologist
Cancer ResearchMedicineOncology
2005English

Prm70 - Non-Small Cell Lung Cancer Market Analysis for Targeted Therapies in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Molecular Targeted Therapies for Pancreatic Cancer

American Journal of Surgery
MedicineSurgery
2008English

A Tabulated Summary of Targeted and Biologic Therapies for Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy